General Notices

• Notice of NICHD Participation in PAR-22-118, International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)"
  (NOT-HD-22-021)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• National Institute on Deafness and Other Communication Disorders (NIDCD) Public Comment Period on its Draft 2022-2027 NIDCD Strategic Plan
  (NOT-DC-22-008)
  National Institute on Deafness and Other Communication Disorders
  

• Request for Information: Call for Nominations for NICHD's Best Pharmaceuticals for Children Act Priorities in Pediatric Therapeutics 2022-2023
  (NOT-HD-22-008)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• NIH Request for Information (RFI) on Integrating Environmental Data into the All of Us Research Program
  (NOT-PM-22-001)
  Office of the Director, NIH
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Maternal and Pediatric Precision in Therapeutics (MPRINT) Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed)
  (NOT-HD-22-013)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network Clinical Research Centers
  (NOT-HD-22-018)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) and other NIH Grantees Conducting Research at RBL-affiliated Sites
  (NOT-AI-22-049)
  National Institute of Allergy and Infectious Diseases
  National Institute of General Medical Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

• Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy
  (NOT-CA-22-063)
  National Cancer Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  

• Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer
  (NOT-CA-22-085)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Administrative Supplements to Support "All of US" and Health Disparities-Related Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
  (NOT-MD-22-015)
  National Institute on Minority Health and Health Disparities
  

• Notice of Special Interest (NOSI): IMPROVE Initiative: Implementation Science to Advance Maternal Health and Maternal Health Equity
  (NOT-OD-22-125)
  Office of the Director, NIH
  

Funding Opportunities

• National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U01 Clinical Trial Optional)
  (PAR-22-143)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional)
  (PAR-22-144)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed)
  (RFA-AG-23-024)
  National Institute on Aging
  Application Receipt Date(s): October 20, 2022
  
  

• NICHD Neonatal Research Network (NRN): Data Coordinating Center (U24 Clinical Trial Optional)
  (RFA-HD-23-001)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): August 11, 2022
  
  

• NICHD Neonatal Research Network (NRN): Clinical Centers (UG1 Clinical Trial Optional)
  (RFA-HD-23-002)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): August 11, 2022
  
  

• NICHD Maternal-Fetal Medicine Units (MFMU) Network: Clinical Centers (UG1 Clinical Trial Optional)
  (RFA-HD-23-016)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): August 11, 2022
  
  

• NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data Coordinating Center (U24 Clinical Trial Optional)
  (RFA-HD-23-017)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): August 11, 2022
  
  

• Emergency Awards: HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed)
  (RFA-NS-22-060)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Dental and Craniofacial Research
  Office of Research on Women's Health
  Application Receipt Date(s): July 15, 2022